Mind Medicine (MindMed) Inc (NASDAQ:MNMD) is trading with mild gains in pre-market trading following a 9.75% on Friday.
Market Action
As of 7:42, MNMD stock gained 0.87% to $3.46 on volume of 109K shares.
MNMD Releases News Today
MindMed Announces Launch of Collaboration with Nextage Therapeutics’ Brain Targeting Liposome System
- announce the execution of a Memorandum of Understanding (the “MOU”) regarding the launch of an exclusive collaborative development program to optimize the delivery of certain psychedelic drug candidates, leveraging Nextage’s proprietary Brain Targeting Liposome System (BTLS) delivery technology, for which it has an exclusive license.
- MindMed and Nextage will initially collaborate to optimize the delivery of drug products based on noribogaine, and ultimately other ibogaine derivatives, and will share development costs and intellectual property arising from the collaboration.
- The BTLS technology is an innovative drug delivery system designed to allow the targeted delivery of active pharmaceutical ingredients (APIs) through the Blood Brain Barrier. BTLS is designed to reduce exposure to the active material outside of the brain, reducing potential risks, intended to substantially lower API concentrations and increasing efficacy.
Trader Notes
Share Information
| SHARES OUTSTANDING | 341.34 M |
| SHARE FLOAT (%) | 308.79 M (90.46%) |
| % HELD BY INSTITUTIONS | 0.11 |
Recent Stock Performance
| 5-DAY PERF. | +6.19% |
| 1-MONTH PERF. | +56.88% |
| 3-MONTH PERF. | -13.82% |
| 6-MONTH PERF. | +174.40% |
| YTD PERF. | +12.46% |
| 1-YEAR PERF. | +716.67% |
Moving Averages
| +/- EMA(20) | 3.32 (+3.31%) |
| +/- SMA(50) | 2.99 (+14.72%) |
| +/- SMA(200) | 2.13 (+61.03%) |
 Is A Pre-market Mover){kind=link}